https://www.ajmc.com/view/data-on-delandistrogene-moxeparvovec-can-inform-future-gene-therapies
The FDA approved delandistrogene moxeparvovec-rokl (Elevidys, Sarepta Therapeutics) in June to treat Duchenne muscular dystrophy in ambulatory pediatric...
delandistrogene moxeparvovecdatainformfuturetherapies